Fabrizio Corti

ORCID: 0000-0003-4601-3344
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Structural Anomalies and Repair
  • Cardiac Valve Diseases and Treatments
  • Cardiac and Coronary Surgery Techniques
  • Cardiac tumors and thrombi
  • Sympathectomy and Hyperhidrosis Treatments
  • Cardiac Ischemia and Reperfusion
  • Cancer Treatment and Pharmacology
  • Pharmacogenetics and Drug Metabolism
  • Cardiac, Anesthesia and Surgical Outcomes
  • Infective Endocarditis Diagnosis and Management
  • Mechanical Circulatory Support Devices
  • Graphite, nuclear technology, radiation studies
  • Pharmacological Receptor Mechanisms and Effects
  • Silymarin and Mushroom Poisoning
  • Chemotherapy-induced organ toxicity mitigation
  • Advanced Numerical Analysis Techniques
  • Childhood Cancer Survivors' Quality of Life
  • Glycogen Storage Diseases and Myoclonus
  • Computer Graphics and Visualization Techniques
  • Pericarditis and Cardiac Tamponade
  • Reconstructive Facial Surgery Techniques
  • Vascular anomalies and interventions
  • Plant-based Medicinal Research
  • Analytical Chemistry and Sensors
  • Facial Trauma and Fracture Management

Azienda Ospedaliera San Gerardo
2007-2022

Indena (Italy)
2021

University of Milano-Bicocca
2006-2015

Fundación Juan March
2007

University of Milan
2005

Italfarmaco (Italy)
1992

Ospedaliera di Piacenza
1988

IRCCS San Camillo Hospital
1988

Mario Negri Institute for Pharmacological Research
1986

Inflammatory response and hemodilution are the main drawbacks of extracorporeal circulation. We hypothesize that use miniaturized circulation (MECC) might lower systemic myocardial inflammatory patterns compared with a standard system (SECC) off-pump coronary artery bypass grafting (OPCABG). Sixty-one patients undergoing isolated graft were prospectively randomized to MECC (n = 19), SECC 20), or OPCABG 22). Blood samples collected from radial sinus analyze blood lactate, hemodilution,...

10.1097/mat.0b013e3182a817aa article EN ASAIO Journal 2013-10-30

To evaluate in vitro solubility, bioaccessibility, and cytotoxic profile, together with a pharmacokinetic profile by oral administration to healthy volunteers of novel food-grade berberine formulation (BBR-PP, i.e., Phytosome®).An increase solubility simulated gastric intestinal fluids an improved bioaccessibility at level along lower cytotoxicity respect were observed BBR-PP. The the confirmed that Phytosome® significantly ameliorated absorption, comparison unformulated berberine, without...

10.1155/2021/7563889 article EN Evidence-based Complementary and Alternative Medicine 2021-11-27

The Trifecta aortic bioprosthesis (St. Jude Medical, Inc., St. Paul, MN, USA) is a stented pericardial heart valve with excellent preliminary results. Aim of the study was to evaluate its early clinical and hemodynamic performances in multicenter regional registry.Between January 2011 June 2012, 178 consecutive patients undergoing replacement were prospectively enrolled at 9 Italian centers. Clinical echocardiographic data collectedat discharge, 6-months 1-year postoperatively.The average...

10.1186/s13019-015-0379-6 article EN cc-by Journal of Cardiothoracic Surgery 2015-11-20

Idiopathic right atrial enlargement is a rare cardiac anomaly presenting as giant atrium. A 20-year-old woman for pneumothorax was found to have pericardial mass compressing ventricle. Echocardiography and magnetic resonance suggested the diagnosis of lone appendance enlargement. The surgically removed histopathology confirmed aneurysm. case notable its rarity.

10.2459/jcm.0b013e32813aee91 article EN Journal of Cardiovascular Medicine 2008-03-01

Abstract Background and aim: We present our experience in the use of right gastroepiploic artery (rGEA). Long-term clinical results are reported. Methods: From April 1994 to June 2005, 271 patients (257 males, mean age 56.2 ± 7.1) underwent coronary bypass grafting with rGEA. Preoperative, perioperative, postoperative data were retrospectively collected survival examined. The end points follow-up death recurrence cardiac events such as angina myocardial infarction (MI). was 8.2 2.9 years....

10.1111/j.1540-8191.2006.00292.x article EN Journal of Cardiac Surgery 2006-09-15

A trigone-to-trigone semirigid annuloplasty band (C-G Future Band, Medtronic, Inc., Minneapolis, Minnesota, USA) was introduced in 2001 for mitral valve repair. We report our early clinical and echocardiographic results with this new device to correct ischemic regurgitation.Between January 2002 December 2004, among 216 patients operated on regurgitation, 107 had a C-G Band 85 consecutive (72.6% male; mean age 66.9 +/- 8.6 years) received regurgitation. Mean follow-up 14.3 9.8 months (range...

10.2459/01.jcm.0000278443.58870.26 article EN Journal of Cardiovascular Medicine 2007-07-01

Two closely related lines of the same Walker 256 carcinoma in Crl-CD/COBS rats, described as behaving differently regards tumor growth and host reaction, show different chemotherapeutic sensitivity to cyclophosphamide (CPA). Line B, which induces early cachexia with marked anorexia, is only moderately sensitive CPA, while line A, causes mild anorexia terminal cachexia, shows responsiveness cure being attained 75% animals treated a single dose 120 mg/kg 90–100% those given 20 every other day....

10.1159/000226377 article EN Oncology 1986-01-01

10.1016/s0378-4347(00)81086-5 article EN Journal of Chromatography B Biomedical Sciences and Applications 1988-01-01

Anomalies of the left coronary artery are very rare, with an incidence range between .3% and 1.64%. The diagnosis is generally incidental during angiogram, bypass operation, or autopsy. However, sometimes this anomaly not recognized CABG operation can be responsible for recurrence angina after even compromise outcome. We presented a case in which dual anterior from right aortic sinus occasionally was shown angiogram operation; performed because angina.

10.1532/hsf98.20051112 article EN The Heart Surgery Forum 2005-09-12
Coming Soon ...